Bernard Lown, groundbreaking cardiologist, dies at 99 | FDA approves expanded indication for sacubitril/valsartan

Lown was an innovator in the field of arrhythmia research and led the development of the direct current defibrillator. He also helped found an organization that won the Nobel Peace Prize in 1985. 

Manufactured by Novartis under the name Entresto, the medication is now also approved for treating HFpEF. 

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

The study, published in the European Journal of Preventive Cardiology, included data from more than 28,000 patients. 

Compensation for cardiologists has been ample in recent years. Could the healthcare industry’s growing interest in value over volume lead to a change in that trend?

According to the new recommendation, patients with advanced cardiovascular disease are at an especially high risk of COVID-related complications and need to be vaccinated as quickly as possible. 

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”

When is it time to retire? It’s a knotty, uncomfortable yet inevitable question.

A significant proportion of parents delayed or put off healthcare visits and care for their children during the Covid-19 pandemic, according to a new report from the Urban Institute and the Robert Wood Johnson Foundation.